We would like to inform our stakeholders that the HTA Council will accept nominations only from the Department of Health (DOH) and Philippine Health Insurance Corporation (PhilHealth) in 2024, and open the Call for Nominations to other stakeholders in the 4th quarter of 2025 for Cycle 3 Topics based on the status of ongoing assessments. continue reading : STATUS UPDATES ON THE HTA NOMINATIONS FOR CYCLE 3 TOPICS
HTA Council Recommendation on Calcium Hydroxide 80% + Clinoptilolite 20% (Kiti-kitiX) Larvicide
As per the Department of Health (DOH) Department Circular 2024 -0308 published 31 July 2024, the Secretary of Health (SOH) fully concurs with the HTA Council recommendation on the non-financing and non-inclusion of Calcium Hydroxide 80% + Clinoptilolite 20% (Kiti-kitiX) Larvicide in the list of larvicides to be used by the Aedes Borne Viral Diseases continue reading : HTA Council Recommendation on Calcium Hydroxide 80% + Clinoptilolite 20% (Kiti-kitiX) Larvicide
[Advisory] Release of HTA Topic Prioritization List 2024 – Cycle 2 Topics that will proceed to Topic Assessment
Following the stakeholder consultation (23 April 2024), appeals period (12 April to 10 May 2024) on the provisional HTA Topic Prioritization List 2024 – Cycle 2 Topics, and processing of 41 appeals, the HTA Council hereby makes public the FINAL HTA Topic Prioritization List 2024 – Cycle 2 Topics. These prioritized topics will now be continue reading : [Advisory] Release of HTA Topic Prioritization List 2024 – Cycle 2 Topics that will proceed to Topic Assessment
[Advisory] Release of the Provisional TP List (April 2024)
The HTA Council hereby makes public the 2024 Provisional List of Priority HTA Topics for stakeholder consultation from 12 to 26 April 2024. Only appeals that are based on the acceptable grounds, have complete sets of requirements, and submitted on time to the correct email address will be processed. Full list of topics and important continue reading : [Advisory] Release of the Provisional TP List (April 2024)